Munich, Germany

Isabel Schemainda

USPTO Granted Patents = 5 

Average Co-Inventor Count = 10.3

ph-index = 4

Forward Citations = 81(Granted Patents)


Company Filing History:


Years Active: 2003-2008

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Isabel Schemainda

Introduction

Isabel Schemainda, based in Munich, Germany, is a notable inventor who has significantly contributed to the field of medicinal chemistry. With a portfolio of five patents, her work is primarily focused on developing novel compounds that serve as cytostatic and immunosuppressive agents. Her inventions aim to address pressing medical needs, particularly in the treatment of tumors and autoimmune diseases.

Latest Patents

Schemainda's latest patents include the following:

1. **Aryl-substituted pyridylalkane, alkene, and alkine carboxamides** - This invention involves new pyridylalkane, alkene, and alkine acid amides that are substituted with an aryl and/or heteroaryl residue. It encompasses methods for synthesizing these compounds and outlines their therapeutic uses as cytostatic and immunosuppressive agents, facilitating the treatment and prevention of various tumors and the control of autoimmune reactions.

2. **Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides** - This patent relates to pyridylalkane, alkene, and alkine carboxamides that feature cyclic imide substitutions. It highlights methods for producing these compounds and describes their use as medicaments, particularly in addressing tumor growth and managing immune responses in autoimmune diseases.

Career Highlights

Isabel Schemainda has collaborated with several esteemed organizations throughout her career, including Klinge Pharma GmbH and Astellas Deutschland GmbH. Her work in these companies has facilitated advancements in drug development, allowing her to translate scientific research into practical therapeutic applications.

Collaborations

Throughout her journey, Schemainda has worked alongside talented colleagues, including Elfi Biedermann and Max Hasmann. These collaborations have enriched her research and contributed to her innovative patent portfolio, exemplifying the power of teamwork in scientific discovery.

Conclusion

Isabel Schemainda's contributions to the field of medicinal chemistry are both impactful and noteworthy. Her innovative patents have the potential to revolutionize treatment options for various medical conditions, particularly in oncology and immunology. Through her dedication and collaboration with other experts, she continues to push the boundaries of scientific knowledge and application, making significant strides in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…